BIOMAT Database Logo BIOMAT Database Logo

Plasma thyrotropin response to thyrotropin-releasing hormone in patients with pituitary and hypothalamic disorders. 1973

G Faglia, and P Beck-Peccoz, and C Ferrari, and B Ambrosi, and A Spada, and P Travaglini, and S Paracchi

UI MeSH Term Description Entries
D007018 Hypopituitarism Diminution or cessation of secretion of one or more hormones from the anterior pituitary gland (including LH; FOLLICLE STIMULATING HORMONE; SOMATOTROPIN; and CORTICOTROPIN). This may result from surgical or radiation ablation, non-secretory PITUITARY NEOPLASMS, metastatic tumors, infarction, PITUITARY APOPLEXY, infiltrative or granulomatous processes, and other conditions. Adenohypophyseal Hyposecretion,Anterior Pituitary Hyposecretion Syndrome,Sheehan Syndrome,Simmonds Disease,Hyposecretion Syndrome, Anterior Pituitary,Hyposecretion, Adenohypophyseal,Pituitary Insufficiency,Postpartum Hypopituitarism,Postpartum Panhypopituitarism,Postpartum Pituitary Insufficiency,Sheehan's Syndrome,Simmonds' Disease,Disease, Simmonds,Hypopituitarism, Postpartum,Insufficiency, Pituitary,Panhypopituitarism, Postpartum,Pituitary Insufficiency, Postpartum,Sheehans Syndrome,Simmond's Disease,Syndrome, Sheehan,Syndrome, Sheehan's
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D010911 Pituitary Neoplasms Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA. Pituitary Cancer,Cancer of Pituitary,Cancer of the Pituitary,Pituitary Adenoma,Pituitary Carcinoma,Pituitary Tumors,Adenoma, Pituitary,Adenomas, Pituitary,Cancer, Pituitary,Cancers, Pituitary,Carcinoma, Pituitary,Carcinomas, Pituitary,Neoplasm, Pituitary,Neoplasms, Pituitary,Pituitary Adenomas,Pituitary Cancers,Pituitary Carcinomas,Pituitary Neoplasm,Pituitary Tumor,Tumor, Pituitary,Tumors, Pituitary
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003397 Craniopharyngioma A benign pituitary-region neoplasm that originates from Rathke's pouch. The two major histologic and clinical subtypes are adamantinous (or classical) craniopharyngioma and papillary craniopharyngioma. The adamantinous form presents in children and adolescents as an expanding cystic lesion in the pituitary region. The cystic cavity is filled with a black viscous substance and histologically the tumor is composed of adamantinomatous epithelium and areas of calcification and necrosis. Papillary craniopharyngiomas occur in adults, and histologically feature a squamous epithelium with papillations. (From Joynt, Clinical Neurology, 1998, Ch14, p50) Craniopharyngioma, Adamantinous,Craniopharyngioma, Papillary,Rathke Pouch Tumor,Craniopharyngioma, Adult,Craniopharyngioma, Child,Neoplasm, Rathke Cleft,Neoplasm, Rathke's Cleft,Rathke Cleft Neoplasm,Rathke's Cleft Neoplasm,Rathke's Pouch Tumor,Adamantinous Craniopharyngioma,Adamantinous Craniopharyngiomas,Adult Craniopharyngioma,Adult Craniopharyngiomas,Child Craniopharyngioma,Child Craniopharyngiomas,Craniopharyngiomas,Craniopharyngiomas, Adamantinous,Craniopharyngiomas, Adult,Craniopharyngiomas, Child,Craniopharyngiomas, Papillary,Neoplasm, Rathkes Cleft,Papillary Craniopharyngioma,Papillary Craniopharyngiomas,Rathkes Cleft Neoplasm,Rathkes Pouch Tumor,Tumor, Rathke Pouch,Tumor, Rathke's Pouch
D003919 Diabetes Insipidus A disease that is characterized by frequent urination, excretion of large amounts of dilute URINE, and excessive THIRST. Etiologies of diabetes insipidus include deficiency of antidiuretic hormone (also known as ADH or VASOPRESSIN) secreted by the NEUROHYPOPHYSIS, impaired KIDNEY response to ADH, and impaired hypothalamic regulation of thirst.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G Faglia, and P Beck-Peccoz, and C Ferrari, and B Ambrosi, and A Spada, and P Travaglini, and S Paracchi
Prolactin response to thyrotropin-releasing hormone (TRH) in patients with hypothalamic-pituitary disease.
January 1985, Fertility and sterility,
G Faglia, and P Beck-Peccoz, and C Ferrari, and B Ambrosi, and A Spada, and P Travaglini, and S Paracchi
Thyrotropin response to thyrotropin-releasing hormone in rats with hypothalamic knife cuts.
October 1987, Neuroendocrinology,
G Faglia, and P Beck-Peccoz, and C Ferrari, and B Ambrosi, and A Spada, and P Travaglini, and S Paracchi
Growth hormone secretory status is a determinant of the thyrotropin response to thyrotropin-releasing hormone in euthyroid patients with hypothalamic-pituitary disease.
February 1981, The Journal of clinical endocrinology and metabolism,
G Faglia, and P Beck-Peccoz, and C Ferrari, and B Ambrosi, and A Spada, and P Travaglini, and S Paracchi
Pituitary response to thyrotropin-releasing hormone in depression.
November 1976, Archives of general psychiatry,
G Faglia, and P Beck-Peccoz, and C Ferrari, and B Ambrosi, and A Spada, and P Travaglini, and S Paracchi
Serum prolactin and growth hormone response to thyrotropin-releasing hormone in patients with pituitary adenomas.
May 1989, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
G Faglia, and P Beck-Peccoz, and C Ferrari, and B Ambrosi, and A Spada, and P Travaglini, and S Paracchi
Plasma thyrotropin (TSH) response to hypothalamic electrical stimulation and to injection of synthetic thyrotropin releasing hormone (TRH).
April 1972, Endocrinology,
G Faglia, and P Beck-Peccoz, and C Ferrari, and B Ambrosi, and A Spada, and P Travaglini, and S Paracchi
Hypothalamic hypothyroidism: diminished thyroidal response to thyrotropin-releasing hormone.
April 1973, The American journal of the medical sciences,
G Faglia, and P Beck-Peccoz, and C Ferrari, and B Ambrosi, and A Spada, and P Travaglini, and S Paracchi
Clinical response to CB-154 and the pituitary response to thyrotropin-releasing hormone-gonadotropin-releasing hormone in patients with galactorrhea-amenorrhea.
May 1977, Fertility and sterility,
G Faglia, and P Beck-Peccoz, and C Ferrari, and B Ambrosi, and A Spada, and P Travaglini, and S Paracchi
Pituitary response to thyrotropin releasing hormone in children with overweight and obesity.
August 2016, Scientific reports,
G Faglia, and P Beck-Peccoz, and C Ferrari, and B Ambrosi, and A Spada, and P Travaglini, and S Paracchi
[The usefulness of TRF (thyrotropin releasing factor) test in patients with hypothalamic-pituitary disorders].
April 1973, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Copied contents to your clipboard!